Homocysteine: More than just a matter of life and death

Experimental Neurology

Volumn 205, Issue 1, 2007, Pages 5-8

  Doherty, G H ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; AMYLOID BETA PROTEIN; CALCIUM; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HOMOCYSTEINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEVODOPA; METABOTROPIC RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITROGEN; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CALCIUM TRANSPORT; CELL SURVIVAL; CELL VIABILITY; CLINICAL FEATURE; DEGENERATIVE DISEASE; DISEASE COURSE; DNA DAMAGE; GENETIC TRANSCRIPTION; HEALTH CARE SYSTEM; HUMAN; LIPID PEROXIDATION; MEDICAL RESEARCH; MORTALITY; NERVE CELL PLASTICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEPLETION; RISK FACTOR; SIGNAL TRANSDUCTION;

EID: 34247262029     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2007.02.012     Document Type: Note

References (31)

1. Andersson A., Brattstrom L., Israelsson B., Isaksson A., Hamfelt A., and Hultberg B. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status. Eur. J. Clin. Invest. 22 2 (1992) 79-87
2. Au-Yeung K.K., Woo C.W., Sung F.L., Yip J.C., Siow Y.L., and O.K. Hyperhomocysteinemia activates nuclear factor-kappaB in endothelial cells via oxidative stress. Circ. Res. 94 1 (2004) 28-36
3. Bryan J., Calvaresi E., and Hughes D. Short-term folate, vitamin B-12 or vitamin B-6 supplementation slightly affects memory performance but not mood in women of various ages. J. Nutr. 132 6 (2002) 1345-1356
4. Clarke R., Harrison G., Richards S., and Vital Trial Collaborative Group. Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia. J. Intern. Med. 254 1 (2003) 67-75
5. Duan W., Ladenheim B., Cutler R.G., Kruman I.I., Cadet J.L., and Mattson M.P. Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease. J. Neurochem. 80 1 (2002) 101-110
6. Ermak G., and Davies K.J. Calcium and oxidative stress: from cell signaling to cell death. Mol. Immunol. 38 10 (2002) 713-721
7. Ferri C.P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., Hall K., Hasegawa K., Hendrie H., Huang Y., Jorm A., Mathers C., Menezes P.R., Rimmer E., and Scazufca M. Alzheimer's disease international. Global prevalence of dementia: a Delphi consensus study. Lancet 366 9503 (2005) 2112-2117
8. Floyd R.A., and Hensley K. Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol. Aging 23 5 (2002) 795-807
9. Foister N.S.L., Oldreive C.E., Mackie J.B., and Doherty G.H. Embryonic cerebellar granule cells are resistant to homocsyteine-induced necrosis. Dev. Brain Res. 160 (2005) 85-89
10. Garcia A., and Zanibbi K. Homocysteine and cognitive function in elderly people. CMAJ 171 8 (2004) 897-904
11. Gortz P., Hoinkes A., Fleischer W., Otto F., Schwahn B., Wendel U., and Siebler M. Implications for hyperhomocysteinemia: not homocysteine but its oxidized forms strongly inhibit neuronal network activity. J. Neurol. Sci. 218 1-2 (2004) 109-114
12. Grieve A., Butcher S.P., and Griffiths R. Synaptosomal plasma membrane transport of excitatory sulphur amino acid transmitter candidates: kinetic characterisation and analysis of carrier specificity. J. Neurosci. Res. 32 1 (1992) 60-68
13. Kruman I.I., Kumaravel T.S., Lohani A., Pedersen W.A., Cutler R.G., Kruman Y., Haughey N., Lee J., Evans M., and Mattson M.P. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J. Neurosci. 22 5 (2002) 1752-1762
14. Kuhn W., Roebroek R., Blom H., van Oppenraaij D., Przuntek H., Kretschmer A., Buttner T., Woitalla D., and Muller T. Elevated plasma levels of homocysteine in Parkinson's disease. Eur. Neurol. 40 4 (1998) 225-227
15. Landfield P.W., Pitler T.A., and Applegate M.D. The effects of high Mg2+-to-Ca2+ ratios on frequency potentiation in hippocampal slices of young and aged rats. J. Neurophysiol. 56 3 (1986) 797-811
16. Lee S.J., Kim K.M., Namkoong S., Kim C.K., Kang Y.C., Lee H., Ha K.S., Han J.A., Chung H.T., Kwon Y.G., and Kim Y.M. Nitric oxide inhibition of homocysteine-induced human endothelial cell apoptosis by down-regulation of p53-dependent Noxa expression through the formation of S-nitrosohomocysteine. J. Biol. Chem. 280 7 (2005) 5781-5788
17. Lipton S.A., Kim W.K., Choi Y.B., Kumar S., D'Emilia D.M., Rayudu P.V., Arnelle D.R., and Stamler J.S. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-d-aspartate receptor. Proc. Natl. Acad. Sci. U. S. A. 94 11 (1997) 5923-5928
18. Liu J., Head E., Gharib A.M., Yuan W., Ingersoll R.T., Hagen T.M., Cotman C.W., and Ames B.N. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-l-carnitine and/or R-alpha-lipoic acid. Proc. Natl. Acad. Sci. U. S. A. 99 4 (2002) 2356-2361 (Erratum in: Proc. Natl. Acad. Sci. U. S. A 2002; 99(10):7184-5)
19. Lu C., Chan S.L., Haughey N., Lee W.T., and Mattson M.P. Selective and biphasic effect of the membrane lipid peroxidation product 4-hydroxy-2,3-nonenal on N-methyl-D-aspartate channels. J. Neurochem. 78 3 (2001) 577-589
20. Malouf M., Grimley E.J., and Areosa S.A. Folic acid with or without vitamin B12 for cognition and dementia. Cochrane Database Syst. Rev. 4 (2003) (CD004514)
21. Mattson M.P. NF-kappaB in the survival and plasticity of neurons. Neurochem. Res. 30 6-7 (2005) 883-893
22. McCaddon A., Davies G., Hudson P., Tandy S., and Cattell H. Total serum homocysteine in senile dementia of Alzheimer type. Int. J. Geriatr. Psychiatry 13 4 (1998) 235-239
23. McCaddon A., Regland B., Hudson P., and Davies G. Functional vitamin B(12) deficiency and Alzheimer disease. Neurology 58 9 (2002) 1395-1399
24. Miller J.W., Selhub J., Nadeau M.R., Thomas C.A., Feldman R.G., and Wolf P.A. Effect of l-dopa on plasma homocysteine in PD patients: relationship to B-vitamin status. Neurology 60 7 (2003) 1125-1129
25. Morris M.C., Evans D.A., Bienias J.L., Tangney C.C., Hebert L.E., Scherr P.A., and Schneider J.A. Dietary folate and vitamin B12 intake and cognitive decline among community-dwelling older persons. Arch. Neurol. 62 4 (2005) 641-645
26. Seshadri S., Beiser A., Selhub J., Jacques P.F., Rosenberg I.H., D'Agostino R.B., Wilson P.W., and Wolf P.A. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346 7 (2002) 476-483
27. Streck E.L., Vieira P.S., Wannmacher C.M., Dutra-Filho C.S., Wajner M., and Wyse A.T. In vitro effect of homocysteine on some parameters of oxidative stress in rat hippocampus. Metab. Brain Dis. 18 2 (2003) 147-154
28. Wainfan E., and Poirier L.A. Methyl groups in carcinogenesis: effects on DNA methylation and gene expression. Cancer Res. 52 7 Suppl (1992) 2071s-2077s
29. Weiss N. Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function. Curr. Drug Metab. 6 1 (2005) 27-36
30. White A.R., Huang X., Jobling M.F., Barrow C.J., Beyreuther K., Masters C.L., Bush A.I., and Cappai R. Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways. J. Neurochem. 76 5 (2001) 1509-1520
31. Zieminska E., Stafiej A., and Lazarewicz J.W. Role of group I metabotropic glutamate receptors and NMDA receptors in homocysteine-evoked acute neurodegeneration of cultured cerebellar granule neurones. Neurochem. Int. 43 4-5 (2003) 481-492